PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Virology Department, Angers University Hospital, Angers, France.\', \'Virology Department, Angers University Hospital, Angers, France; HIFIH Laboratory EA 3859, LUNAM, Angers, France.\', \'Department of Biochemistry and Genetics, Angers University Hospital, Angers, France.\', \'Infectious Diseases and Tropical Medicine, University Hospital of Angers, Angers, France; Equipe ATIP AVENIR, CRCINA, INSERM, University of Nantes and Angers.\', \'Medical Intensive Care Department, University Hospital of Angers, Angers, France.\', \'Virology Department, Angers University Hospital, Angers, France; HIFIH Laboratory EA 3859, LUNAM, Angers, France. Electronic address: heleguillou@chu-angers.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1386-6532(20)30253-510.1016/j.jcv.2020.104511
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 32593133
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all